These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29310956)

  • 1. Medication History versus Point-of-Care Platelet Activity Testing in Patients with Intracerebral Hemorrhage.
    Maas MB; Naidech AM; Kim M; Batra A; Manno EM; Sorond FA; Prabhakaran S; Liotta EM
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1167-1173. PubMed ID: 29310956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled Trial.
    Law ZK; Desborough M; Roberts I; Al-Shahi Salman R; England TJ; Werring DJ; Robinson T; Krishnan K; Dineen R; Laska AC; Peters N; Egea-Guerrero JJ; Karlinski M; Christensen H; Roffe C; Bereczki D; Ozturk S; Thanabalan J; Collins R; Beridze M; Bath PM; Sprigg N
    J Am Heart Assoc; 2021 Feb; 10(5):e019130. PubMed ID: 33586453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage.
    Naidech AM; Bassin SL; Bernstein RA; Batjer HH; Alberts MJ; Lindholm PF; Bleck TP
    Neurocrit Care; 2009 Dec; 11(3):307-10. PubMed ID: 19381881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage.
    Naidech AM; Jovanovic B; Liebling S; Garg RK; Bassin SL; Bendok BR; Bernstein RA; Alberts MJ; Batjer HH
    Stroke; 2009 Jul; 40(7):2398-401. PubMed ID: 19443791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Administration of Desmopressin and Platelet Transfusion for Reducing Hematoma Expansion in Patients With Acute Antiplatelet Therapy Associated Intracerebral Hemorrhage.
    Mengel A; Stefanou MI; Hadaschik KA; Wolf M; Stadler V; Poli K; Lindig T; Ernemann U; Grimm F; Tatagiba M; Ziemann U; Poli S
    Crit Care Med; 2020 Jul; 48(7):1009-1017. PubMed ID: 32304415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage.
    Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; DeRosa PA; Landes E; Lei S; Khandji J; Gutbrod S; Connolly ES
    Neurol Res; 2010 Sep; 32(7):706-10. PubMed ID: 20819399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage.
    Giede-Jeppe A; Bobinger T; Gerner ST; Sembill JA; Sprügel MI; Beuscher VD; Lücking H; Hoelter P; Kuramatsu JB; Huttner HB
    Cerebrovasc Dis; 2017; 44(1-2):26-34. PubMed ID: 28419988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced platelet activity is associated with more intraventricular hemorrhage.
    Naidech AM; Bendok BR; Garg RK; Bernstein RA; Alberts MJ; Bleck TP; Batjer HH
    Neurosurgery; 2009 Oct; 65(4):684-8; discussion 688. PubMed ID: 19834372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Previous antiplatelet use is associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage.
    Yildiz OK; Arsava EM; Akpinar E; Topcuoglu MA
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):760-6. PubMed ID: 21683617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage.
    Liotta EM; Prabhakaran S; Sangha RS; Bush RA; Long AE; Trevick SA; Potts MB; Jahromi BS; Kim M; Manno EM; Sorond FA; Naidech AM; Maas MB
    Neurology; 2017 Aug; 89(8):813-819. PubMed ID: 28747450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activity and outcome after intracerebral hemorrhage.
    Naidech AM; Bernstein RA; Levasseur K; Bassin SL; Bendok BR; Batjer HH; Bleck TP; Alberts MJ
    Ann Neurol; 2009 Mar; 65(3):352-6. PubMed ID: 19334079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage.
    Moussouttas M; Malhotra R; Fernandez L; Maltenfort M; Holowecki M; Delgado J; Lawson N; Badjatia N
    Neurocrit Care; 2010 Feb; 12(1):24-9. PubMed ID: 19844810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta-analysis.
    Camps-Renom P; Alejaldre-Monforte A; Delgado-Mederos R; Martínez-Domeño A; Prats-Sánchez L; Pascual-Goñi E; Martí-Fàbregas J
    Eur J Neurol; 2017 Feb; 24(2):302-308. PubMed ID: 27801531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
    Cerebrovasc Dis; 2020; 49(2):177-184. PubMed ID: 32320990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage.
    Qureshi AI; Palesch YY; Martin R; Novitzke J; Cruz-Flores S; Ehtisham A; Ezzeddine MA; Goldstein JN; Kirmani JF; Hussein HM; Suri MF; Tariq N; Liu Y;
    Neurocrit Care; 2011 Dec; 15(3):428-35. PubMed ID: 21573860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH.
    Sansing LH; Messe SR; Cucchiara BL; Cohen SN; Lyden PD; Kasner SE;
    Neurology; 2009 Apr; 72(16):1397-402. PubMed ID: 19129506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmopressin improves platelet activity in acute intracerebral hemorrhage.
    Naidech AM; Maas MB; Levasseur-Franklin KE; Liotta EM; Guth JC; Berman M; Rosenow JM; Lindholm PF; Bendok BR; Prabhakaran S; Bernstein RA; Kwaan HC
    Stroke; 2014 Aug; 45(8):2451-3. PubMed ID: 25005444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Black Hole Sign Predicts Poor Outcome in Patients with Intracerebral Hemorrhage.
    Li Q; Yang WS; Chen SL; Lv FR; Lv FJ; Hu X; Zhu D; Cao D; Wang XC; Li R; Yuan L; Qin XY; Xie P
    Cerebrovasc Dis; 2018; 45(1-2):48-53. PubMed ID: 29402824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
    Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Magnesium Levels and Outcomes in Patients With Acute Spontaneous Intracerebral Hemorrhage.
    Goyal N; Tsivgoulis G; Malhotra K; Houck AL; Khorchid YM; Pandhi A; Inoa V; Alsherbini K; Alexandrov AV; Arthur AS; Elijovich L; Chang JJ
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.